These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10618556)

  • 21. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of magnesium infusion on thrombolytic and non-thrombolytic treated patients with acute myocardial infarction.
    Thögersen AM; Johnson O; Wester PO
    Int J Cardiol; 1993 Apr; 39(1):13-22. PubMed ID: 7691765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial).
    Mewton N; Cung TT; Morel O; Cayla G; Bonnefoy-Cudraz E; Rioufol G; Angoulvant D; Guerin P; Elbaz M; Delarche N; Coste P; Vanzetto G; Metge M; Aupetit JF; Jouve B; Motreff P; Tron C; Labeque JN; Steg PG; Cottin Y; Range G; Clerc J; Coussement P; Prunier F; Moulin F; Roth O; Belle L; Dubois P; Barragan P; Gilard M; Piot C; Colin P; Morice MC; Monassier JP; Ider O; Dubois-Randé JL; Unterseeh T; Lebreton H; Beard T; Blanchard D; Grollier G; Malquarti V; Staat P; Sudre A; Hansson MJ; Elmer E; Boussaha I; Jossan C; Torner A; Claeys M; Garcia-Dorado D; Ovize M;
    Am Heart J; 2015 Jun; 169(6):758-766.e6. PubMed ID: 26027612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early intravenous magnesium administration in acute myocardial infarction.
    Fernandes JS
    Magnes Res; 1994 Dec; 7(3-4):341-3. PubMed ID: 7786697
    [No Abstract]   [Full Text] [Related]  

  • 25. Is there a place for magnesium in the treatment of acute myocardial infarction?
    Seelig MS; Elin RJ
    Am Heart J; 1996 Aug; 132(2 Pt 2 Su):471-7; discussion 496-502. PubMed ID: 8694006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.
    Berger JS; Roe MT; Gibson CM; Kilaru R; Green CL; Melton L; Blankenship JD; Metzger DC; Granger CB; Gretler DD; Grines CL; Huber K; Zeymer U; Buszman P; Harrington RA; Armstrong PW
    Am Heart J; 2009 Dec; 158(6):998-1004.e1. PubMed ID: 19958867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction.
    Balkin J; Rosenmann D; Ilan M; Klutstein M; Zion MM; Abraham AS
    Magnes Res; 1994 Dec; 7(3-4):267-71. PubMed ID: 7786689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myocardial infarction, reperfusion injury, and intravenous magnesium therapy: basic concepts and clinical implications.
    Steurer G; Yang P; Rao V; Mohl W; Glogar D; Smetana R
    Am Heart J; 1996 Aug; 132(2 Pt 2 Su):478-82; discussion 496-502. PubMed ID: 8694007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rationale of magnesium as alternative therapy for patients with acute myocardial infarction without thrombolytic therapy.
    Shechter M; Hod H; Kaplinsky E; Rabinowitz B
    Am Heart J; 1996 Aug; 132(2 Pt 2 Su):483-6; discussion 496-502. PubMed ID: 8694008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction.
    Roffe C; Fletcher S; Woods KL
    Br Heart J; 1994 Feb; 71(2):141-5. PubMed ID: 8130021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of magnesium in acute myocardial infarct].
    Beuckelmann DJ
    Z Kardiol; 1996; 85 Suppl 6():129-34. PubMed ID: 9064957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial.
    Ghaffari S; Kazemi B; Golzari IG
    Cardiovasc Ther; 2013 Feb; 31(1):53-9. PubMed ID: 21884018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Imai K; Murohara T; Matsubara T
    Circulation; 2005 Aug; 112(9):1284-8. PubMed ID: 16116055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy.
    Shechter M; Hod H; Chouraqui P; Kaplinsky E; Rabinowitz B
    Am J Cardiol; 1995 Feb; 75(5):321-3. PubMed ID: 7856520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study.
    Scirica BM; Sabatine MS; Morrow DA; Gibson CM; Murphy SA; Wiviott SD; Giugliano RP; McCabe CH; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2006 Jul; 48(1):37-42. PubMed ID: 16814646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of intravenous magnesium therapy in thrombolysis-ineligible acute myocardial infarction patients.
    Shechter M; Hod H; Rabinowitz B; Boyko V; Chouraqui P
    Cardiology; 2003; 99(4):205-10. PubMed ID: 12845247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of intravenous administration of SO4Mg in the acute phase of myocardial infarct].
    Pereira D; Pereira TG; Rabaçal C; Carvalho E; Linder J; Afonso JS; Pereira JN; Halpern MJ; Fernandes JS
    Rev Port Cardiol; 1990 Mar; 9(3):205-10. PubMed ID: 2390281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.